Search for: "Robertson v. Howes" Results 1 - 20 of 401
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Apr 2024, 9:30 pm by The Regulatory Review
Sepper explained how the U.S. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
1 Apr 2024, 8:17 am
Any further communication by you to Randy Robertson or anyone else at BlackRock regarding this matter will be considered by Aviron to constitute tortious interference. [read post]
10 Jan 2024, 1:27 am by Joshua Matz
Michaels Professor of Law UCLA School of Law Timothy Naftali Senior Research Scholar Columbia University School of International and Public Affairs Victoria Nourse Ralph V. [read post]
24 Dec 2023, 9:05 pm by The Regulatory Review
How Patents Contribute to High Drug Prices October 16, 2023 | Laura Dolbow, University of Pennsylvania Carey Law School Patents covering drugs selected for Medicare price negotiation show how patents influence drug prices. [read post]
27 Oct 2023, 11:47 am by McKennon Law Group
The court noted that failure to conduct an IME may be particularly dubious when a claimant’s condition is based on subjective symptoms, citing Robertson v. [read post]
1 Sep 2023, 4:00 am by Jim Sedor
The justices faced heightened security risks, Thomas noted, after the leak of the court’s majority opinion to overturn Roe v. [read post]
12 Aug 2023, 11:41 pm by Frank Cranmer
David G Robertson, LSE Religion and Global Society: In Good Faith? [read post]